Business and Finance Business and Finance
Mon, March 4, 2013
Sun, March 3, 2013

DSM completes sale of participation in DEXPlastomers JV to Borealis


Published on 2013-03-04 01:01:00 - Market Wire
  Print publication without navigation


March 04, 2013 02:40 ET

DSM completes sale of participation in DEXPlastomers JV to Borealis

HEERLEN, THE NETHERLANDS--(Marketwire - Mar 4, 2013) - Royal DSM, the global Life Sciences and Materials Sciences company, announced today that it has completed the sale of its participation in DEXPlastomers V.o.F, a 50/50 Joint Venture of DSM with an affiliate of ExxonMobil Chemical, to Borealis. DSM also sold its LldPE Compact Solution Technology to Borealis. The transaction was announced in November 2012.

Established in 1996, DEXPlastomers is a 50/50 joint venture between DSM and Exxon Chemical Holland Ventures B.V., producing C8 plastomers and linear low density polyethylene. In the scope of the transaction are approximately 100 employees who have transferred to the new owner upon closing. DSM's LldPE Compact Solution Technology was first developed in the 1960's to produce polyethylenes in a certain density range and is instrumental to the operations of DEXPlastomers.

For DSM, a sale of DEXPlastomers is in line with its long-term focus of being a Life Sciences and Materials Sciences company, active in health, nutrition and materials. DSM's 50% participation in DEXPlastomers was reported under Corporate Activities in DSM's accounts.

DSM - Bright Science. Brighter Living.™

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 23,500 employees deliver annual net sales of around EUR9 billion. The company is listed on NYSE Euronext. More information can be found at [ www.dsm.com ].

Or find us on:

[ http://www.facebook.com/DSMcompany ]

[ http://twitter.com/DSM ]

[ http://www.linkedin.com/company/3108 ]

[ http://www.youtube.com/user/dsmcompany ]

Press release-pdf:

[ http://hugin.info/130663/R/1682603/550446.pdf ]

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE

[HUG#1682603]


Contributing Sources